Stigmatization experience, coping and sense of coherence in vitiligo patients

Journal of the European Academy of Dermatology and Venereology

Volumn 21, Issue 4, 2007, Pages 456-461

  Schmid Ott, Gerhard ^a   Kunsebeck H W ^a   Jecht, E ^a   Shimshoni, R ^a   Lazaroff, I ^a   Schallmayer, S ^a   Calliess, I T ^a   Malewski, P ^a   Lamprecht, F ^a   Gotz A ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Castle of Friedensburg ^*  (Germany)

Author keywords

Coping; Questionnaire; Sense of coherence; Stigmatization; Stress; Vitiligo

Indexed keywords

ADULT; AGE; ARTICLE; CONTROLLED STUDY; COPING BEHAVIOR; CORRELATION ANALYSIS; DATA ANALYSIS; DISEASE DURATION; FEMALE; GENDER; HUMAN; ILLNESS BEHAVIOR; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PERSONAL EXPERIENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SAMPLE SIZE; SCORING SYSTEM; SELF ESTEEM; SKIN DEFECT; STIGMA; VITILIGO;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; ANXIETY; ATTITUDE TO HEALTH; DEPRESSION; FEMALE; HUMANS; MALE; QUALITY OF LIFE; REJECTION (PSYCHOLOGY); SELF ASSESSMENT (PSYCHOLOGY); SELF CONCEPT; SKIN; SOCIAL ADJUSTMENT; SOCIAL BEHAVIOR; SOCIAL DESIRABILITY; STEREOTYPING; VITILIGO;

EID: 33947357391     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01897.x     Document Type: Article

References (32)

1. Njoo MD, Westerhof W. Vitiligo. Pathogenesis and treatment. Am J Clin Dermatol 2001; 2: 167-181.
2. Mantovani S, Garbelli S, Palermo B et al. Molecular and functional bases of self-antigen recognition in long-term persistent melanocyte-specific CD8+ T cells in one vitiligo patient. J Invest Dermatol 2003; 121: 308-314.
3. Yildirim M, Baysal V, Inaloz HS et al. The role of oxidants and antioxidants in generalized vitiligo at tissue level. J Eur Acad Dermatol Venereol 2004; 18: 683-686.
4. Grimes PE. New insights and new therapies in vitiligo. JAMA 2005; 293: 730-735.
5. Tjioe M, Otero ME, van de Kerkhof PC et al. Quality of life in vitiligo patients after treatment with long-term narrowband ultraviolet B phototherapy. J Eur Acad Dermatol Venereol 2005; 19: 56-60.
6. Ginsburg IH, Link BG. Feelings of stigmatization in patients with psoriasis. J Am Acad Dermatol 1989; 20: 53-63.
7. Kent G, Al'Abadie M. Factors affecting responses on dermatology life quality index items among vitiligo sufferers. Clin Exp Dermatol 1996; 21: 330-333.
8. Schmid-Ott G, Jäger B, Künsebeck HW et al. Psychosocial influences on the illness experience of psoriasis patients. A study with the 'Questionnaire on Experience with Skin Complaints' QES. ZKKP (Zeitschrift für Klinische Psychologie, Psychiatrie und Psychotherapie) 1998; 46: 330-343.
9. Schmid-Ott G, Künsebeck HW, Jäger B et al. Significance of the stigmatization experience of psoriasis patients: A 1-year follow-up of the illness and its psychosocial consequences in men and women. Acta Derm Venereol (Stockh) 2005; 85: 27-32.
10. Mattoo SK, Handa S, Kaur I et al. Psychiatric morbidity in vitiligo: prevalence and correlates in India. J Eur Acad Dermatol Venereol 2002; 16: 573-578.
11. Chren MM, Weinstock MA. Conceptual issues in measuring the burden of skin diseases. J Invest Dermatol Symp Proc 2004; 9: 97-100.
12. Parsad D, Pandhi R, Dogra S et al. Dermatology life quality index score in vitiligo and its impact on the treatment outcome. Br J Dermatol 2003; 148: 373-374.
13. Gieler U, Brosig B, Schneider U et al. Vitiligo - coping behavior. Dermatol Psychosom 2000; 1: 6-10.
14. de Korte J, Van Onselen J, Kownacki S et al. Quality of care in patients with psoriasis: An initial clinical study of an international disease management programme. J Eur Acad Dermatol Venereol 2005; 19: 35-41.
15. van de Kerkhof PC. The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/Dovobet) on the quality of life in patients with psoriasis vulgaris: A randomized controlled trial. Br J Dermatol 2004; 151: 663-668.
16. Yazici K, Baz K, Yazici AE et al. Disease-specific quality of life is associated with anxiety and depression in patients with acne. J Eur Acad Dermatol Venereol 2004; 18: 435-439.
17. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
18. Antonovsky A. Unraveling the Mystery of Health. How People Manage Stress and Stay Well. Jossey-Bass, San Francisco, 1987.
19. Kivimaki M, Feldt T, Vahtera J et al. Sense of coherence and health: evidence from two cross-lagged longitudinal samples. Soc Sci Med 2000; 50: 583-597.
20. Stangier U, Gieler U, Ehlers A. Measuring adjustment to chronic skin disorders: Validation of a self-report measure. Psychol Assess 2003; 15: 532-549.
21. Feldman SR, Fleischer AB Jr, Reboussin DM et al. The self-administered psoriasis area and severity index is valid and reliable. J Invest Dermatol 1996; 106: 183-186.
22. Fredriksson T, Petersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978; 157: 238-244.
23. Conolly TG, Slickin W. An Introduction to Statistics for the Social Sciences. Macmillan, London, 1971.
24. Fitzpatrick TB, Eisen AZ, Wolff K et al. Dermatology in General Medicine, 5th edn. McGraw-Hill, New York, 1998.
25. Thompson AR, Kent G, Smith JA. Living with vitiligo: Dealing with difference. Br J Health Psychol 2002; 7: 213-225.
26. Hughes JE, Barraclough BM, Hamblin LG et al. Psychiatric symptoms in dermatology patients. Br J Psychiatry 1983; 143: 51-54.
27. Picardi A, Abeni D, Renzi C et al. Increased psychiatric morbidity in female outpatients with skin lesions on visible parts of the body. Acta Derm Venereol 2001; 81: 410-414.
28. Picardi A, Pasquini P, Cattaruzza MS et al. Stressful life events, social support, attachment security and alexithymia in vitiligo. A case-control study. Psychother Psychosom 2003; 72: 150-158.
29. Stone J, Carson A, Sharpe M. Wall between neurology and psychiatry. Some parts of the wall are thicker than others. BMJ 2002; 325: 778.
30. Stone J, Colyer M, Feltbower S et al. 'Psychosomatic': A systematic review of its meaning in newspaper articles. Psychosomatics 2004; 45: 287-290.
31. Cassano P, Fava M. Depression and public health - an overview. J Psychosom Res 2002; 53: 849-857.
32. Papadopoulos L, Bor R, Legg C. Coping with the disfiguring effects of vitiligo: A preliminary investigation into the effects of cognitive-behavioural therapy. Br J Med Psychol 1999; 72: 385-396.